Canton Strategic Holdings, Inc. (CNTN)
NASDAQ: CNTN · Real-Time Price · USD
3.020
+0.040 (1.34%)
At close: May 8, 2026, 4:00 PM EDT
3.040
+0.020 (0.66%)
Pre-market: May 11, 2026, 5:22 AM EDT
Canton Strategic Holdings Market Cap
Canton Strategic Holdings has a market cap or net worth of $171.1 million as of May 11, 2026. Its market cap has increased by 6,633.52% in one year.
Market Cap
171.10M
Enterprise Value
154.07M
1-Year Change
6,633.52%
Ranking
Category
Stock Price
$3.02
Market Cap Chart
Since January 12, 2022, Canton Strategic Holdings's market cap has increased from $32.56M to $171.10M, an increase of 425.46%. That is a compound annual growth rate of 46.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 171.10M | 54.94% |
| Dec 31, 2025 | 110.43M | 2,713.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -86.20% |
| Jan 12, 2022 | 32.56M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acumen Pharmaceuticals | 184.90M |
| Elicio Therapeutics | 182.31M |
| Korro Bio | 173.79M |
| Polaryx Therapeutics | 173.28M |
| Pyxis Oncology | 172.16M |
| Black Diamond Therapeutics | 171.33M |
| ProQR Therapeutics | 166.47M |
| Oramed Pharmaceuticals | 165.42M |